Andrew M. Evens: Award-Winning Research from the British Society for Haematology 66th Annual Meeting
Andrew M. Evens, Deputy Director for Clinical Services at Rutgers Cancer Institute, Chief Physician Officer at The Jack and Sheryl Morris Cancer Center/Hospital, Professor of Medicine at Rutgers Robert Wood Johnson Medical School, shared a post on LinkedIn:
“A great time at the British Society for Haematology 66th Annual Scientific Meeting in Liverpool, England.
A big kudos to outgoing BSH President, Dr Sue Pavord and CEO, Carol Bewick, for a highly successful symposium with outstanding education and science (and fun social event!).
Dr Phillip Scheinberg and I were thrilled to hand out awards at the Presidential symposium to the top downloaded papers in 2025 for the British Journal of Haematology and eJHaem to Dr Deepa Arachchillage and Dr David Bartlett on Anti-PF4 disorders and QOL and exercise in CLL, respectively.
There were also 3 great presentations at the ‘Best of BJHaem’ session given by Austin Kulasekararaj, on Aplastic anemia, Deepa Arachchillage on Antiphospholipid syndrome and Dr Renata Walewska on CLL.
Finally, we thank all authors for submitting their High Impact papers to our journals, to all of our outstanding Associate Editors for their expertise and year-yound diligent work, and also to our brilliant colleages at Wiley (especially Claire Dowbekin and MK Wang).”
Title: Anti-PF4 disorders: Pathogenesis, diagnosis and treatment
Authors: Megan V. Preece, Devi V. Pathak, Mike Laffan, Deepa J. Arachchillage
Read the Full Article on British Journal of Haematology.
Title: Physical Activity, Symptoms, Quality of Life and Exercise Program Preferences in People With Chronic Lymphocytic Leukaemia
Authors: Ellie E. Miles, Jennifer L. Nicol, Hatti Fowler, Amelia Roberts, Andrew T. Hulton, Caitlin Jeary, Renata Walewska, Sunil Iyengar, Erik D. Hanson, CLL Support Association, Andrea Sitlinger, David B. Bartlett
Read the Full Article on eJHaem.
Title: Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline
Authors: Austin Kulasekararaj, Jamie Cavenagh, Inderjeet Dokal, Theodora Foukaneli, Shreyans Gandhi, Mamta Garg, Morag Griffin, Peter Hillmen, Robin Ireland, Sally Killick, Sahar Mansour, Ghulam Mufti, Victoria Potter, John Snowden, Simon Stanworth, Roslin Zuha, Judith Marsh, the BSH Committee
Read the Full Article on British Journal of Haematology.
Title: Guidelines on the investigation and management of antiphospholipid syndrome
Authors: Deepa J. Arachchillage, Sean Platton, Kieron Hickey, Justin Chu, Matthew Pickering, Peter Sommerville, Peter MacCallum, Karen Breen, the BSH Committee
Read the Full Article on British Journal of Haematology.
Title: 2025 British Society for Haematology Guideline for the treatment of chronic lymphocytic leukaemia
Authors: R. Walewska, T. A. Eyre, A. Bloor, G. Follows, S. Iyengar, R. Johnston, H. Marr, N. Martinez-Calle, A. McCaig, H. McCarthy, T. Munir, H. M. Parry, N. Parry-Jones, A. Pettitt, J. Riches, I. Ringshausen, A. Schuh, P. E. M. Patten
Read the Full Article on British Journal of Haematology.
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 4, 2026, 16:31Javed Anees: When Rheumatic Heart Disease Causes Stroke
-
Aug 4, 2026, 16:15Violeta Jardin: The Missing Link in TXA Use for Postpartum Hemorrhage
-
Aug 4, 2026, 14:43Moustafa Abdou: How to Recognize and Manage Hematologic Emergencies in Time
-
Aug 4, 2026, 14:40Majd A.AbuAlrob: Is TPA Beneficial for Spinal Infarction?
-
Aug 4, 2026, 14:27What Detecting Atrial Fibrillation After Stroke Really Means for Patient Care – International Journal of Stroke
-
Aug 4, 2026, 14:19Caitlin Raymond: Unvaccinated Blood Requests and Their Impact on Patient Safety
-
Aug 4, 2026, 13:50Hamish Aitken-Buck: New Insights Challenge the Role of Histidine Rich Glycoprotein in Thrombosis
-
Aug 4, 2026, 13:38Michalis Gkionis: Dual-Domain Risk Assessment Simplifies Thrombosis Screening
-
Aug 4, 2026, 13:26Damien Luque Paz: Improving Myeloproliferative Neoplasm Diagnosis With Non Invasive Biomarkers